خانه › سرطان ریه غیرسلول کوچک › یوتا › Salt Lake City
آزمایش‌های بالینی سرطان ریه غیرسلول کوچک در Salt Lake City، UT
31 مطالعه برای سرطان ریه غیرسلول کوچک در مراکز Salt Lake City (در شعاع حدود ۳۰ مایل) در جستجوی شرکت‌کننده هستند. یک مطالعه را باز کنید تا شرایط شرکت و نحوه تماس با تیم پژوهشی را ببینید.
متن رسمی مطالعه (انگلیسی)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
در حال جذب شرکت‌کنندهمرحله 1/2
- Huntsman Cancer Institute /ID# 271686, Salt Lake City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
در حال جذب شرکت‌کنندهمرحله 3
- Utah Cancer Specialists, Salt Lake City
- Huntsman Cancer Institute, Salt Lake City
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
در حال جذب شرکت‌کنندهمرحله 3
- Huntsman Cancer Institute ( Site 0042), Salt Lake City
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
در حال جذب شرکت‌کنندهمرحله 3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
در حال جذب شرکت‌کنندهمرحله 2
- Huntsman Cancer Institute, Salt Lake City
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
در حال جذب شرکت‌کنندهمرحله 3
- Local Institution - 0302, Salt Lake City
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
در حال جذب شرکت‌کنندهمرحله 2/3
- Utah Cancer Specialists, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
در حال جذب شرکت‌کنندهمرحله 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
در حال جذب شرکت‌کنندهمرحله 3
- Clinical Study Site, Salt Lake City
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Huntsman Cancer Institute, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- Utah Cancer Specialists, Salt Lake City
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
در حال جذب شرکت‌کنندهمرحله 1
- Huntsman Cancer Institute, Salt Lake City
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
در حال جذب شرکت‌کنندهمرحله 1/2
- University of Utah - Huntsman Cancer Institute - PPDS, Salt Lake City
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Huntsman Cancer Institute, Salt Lake City
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
در حال جذب شرکت‌کنندهمرحله 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- START Mountain Region, Salt Lake City
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
در حال جذب شرکت‌کنندهمرحله 1
- Huntsman Cancer Institute, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
در حال جذب شرکت‌کنندهمرحله 1/2
- Huntsman Cancer Institute, Salt Lake City
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2/3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
در حال جذب شرکت‌کننده
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- Huntsman Cancer Institute, Salt Lake City
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
در حال جذب شرکت‌کنندهمرحله 1/2
- University of Utah, Huntsman Cancer Institute, Salt Lake City
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
در حال جذب شرکت‌کننده
- Huntsman Cancer Institute, Salt Lake City
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
در حال جذب شرکت‌کنندهمرحله 1/2
- Utah Cancer Specialists (site 203), Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- Massive Bio SYNERGY-AI site, Salt Lake City
آزمایش‌های سرطان ریه غیرسلول کوچک در سایر شهرها
- Houston, TX145 مطالعه
- New York City, NY121 مطالعه
- Arlington, VA104 مطالعه
- Nashville, TN97 مطالعه
- Boston, MA90 مطالعه
- Los Angeles, CA87 مطالعه
- St. Louis, MO73 مطالعه
- Chicago, IL61 مطالعه
- Baltimore, MD60 مطالعه
- San Antonio, TX59 مطالعه
- Columbus, OH57 مطالعه
- Washington, DC55 مطالعه
سایر مطالعات در Salt Lake City
- سرطان (همه انواع)27 مطالعه
- سرطان پستان27 مطالعه
- سرطان کولورکتال22 مطالعه
- سرطان ریه21 مطالعه
- ملانوم21 مطالعه
- میلوم متعدد21 مطالعه
- سرطان متاستاتیک20 مطالعه
- سرطان تخمدان19 مطالعه
- چاقی18 مطالعه
- لوکمیه حاد میلویید17 مطالعه
- نارسایی قلبی17 مطالعه
- سرطان پروستات15 مطالعه
از ClinicalTrials.gov، داده‌ها در تاریخ 6 اکتبر 2026 دریافت شده است. هر مطالعه شرایط اختصاصی خود را دارد؛ تیم پژوهشی تصمیم می‌گیرد چه کسانی می‌توانند شرکت کنند.